Startup · AI
Jobs at Kymera Therapeutics
Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer. 28 open roles.
See all 28 roles →Find your next role52208 open roles
Open roles
Jobs at Kymera Therapeutics
28open roles
$180K to $275Ktypical pay · salary guide
Updated weekly.
Last refresh Mon, Sep 28
Showing 1 to 20 of 28 jobs
- Director, Data ManagementKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$195K to $275K
- Manager or Senior Manager, Clinical OutsourcingKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$115K to $215K
- Associate Director or Director, BiostatisticsKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$160K to $275K
- Associate Director or Director, Laboratory Operations and FacilitiesKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$160K to $275K
- Clinical Trial Associate or Senior Clinical Trial AssociateKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$115K to $200K
- Medical Director or Senior Medical DirectorKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$300K to $380K
- Associate Director or Director, Clinical ScientistKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$160K to $275K
- Global Safety Officer (Medical Director / Senior Medical Director)Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$220K to $340K
- Senior Manager or Associate Director, Translational Medicine OperationsKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$145K to $240K
- Director or Senior Director, Program ManagementKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$195K to $330K
- Director or Senior Director, Regulatory CMCKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$195K to $330K
- Associate Director, Analytical DevelopmentKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$160K to $240K
- Director or Senior Director, CMC Program ManagementKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$195K to $330K
- Associate Director, New Product StrategyKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$195K to $275K
- Manager or Senior Manager, Patient Recruitment and RetentionKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$115K to $215K
- Senior Director, Outcomes, Value & AccessKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$235K to $330K
- Associate Director or Director, PBPK & Biopharmaceutics ModelingKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$160K to $275K
- Senior Manager or Associate Director, Feasibility Analytics & InsightsKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$145K to $240K
- IT Director, Development Business PartnerKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$195K to $275K
- Senior Director, Early Phase Formulation DevelopmentKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$235K to $330K
Build your edge while you search
Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.